The rearrangement and expression of human T cell receptor (TCR)-y and -b gene segments in clonal and polyclonal populations of early fetal and postnatal human TCR-7/6 thymocytes were examined. The data suggest that the TCRy and -b loci rearrange in an ordered and coordinated fashion. Initial rearrangements at the TCR-b locus join Vat to D63, and initial rearrangements at the TCR-y locus join downstream Vy gene segments (Vyl.8 and VY2) to upstream JY gene segments associated with Cyl. These rearrangements are characterized by minimal junctional diversity. At later times there is a switch at the TCR-b locus such that V61 is joined to upstream Da gene segments, and a switch at the TCR y locus such that upstream V., gene segments are joined to downstream Jy gene segments associated with CY2. These rearrangements are characterized by extensive junctional diversity. Programmed rearrangement explains in part the origin ofdiscrete subpopulations ofperipheral blood TCRy/b lymphocytes that have been defined in previous studies . In addition, cytokine production by early fetal and postnatal TCR y/b thymocyte clones was examined. Fetal thymocyte clones produced significant levels of114 and IL-5 following stimulation, whereas postnatal thymocyte clones did not produce these cytokines. Thus, these cell populations may represent functionally distinct subsets as well. revious studies of clonal and polyclonal human TCR-y/b lymphocytes derived from peripheral blood have revealed the presence of two major subpopulations based upon variable (V) and constant (C) gene segment usage (1-11) . The majority of peripheral blood TCR yb lymphocytes bear receptors using both V62 and Vy2 (Vy9 in the nomenclature of Lefranc et al. [12]).' The TCR y and b chains of these receptors are disulfide-linked, indicating that the TCR y chains are encoded by Cy l rather than Cy2 (13, 14) . A smaller population of peripheral blood TCR-y/S lymphocytes bear receptors using V61. The majority of these lymphocytes use members of the V.y1 gene family, rather than VY2, and the TCR y and b chains of these receptors are frequently non-disulfide linked, indicating that the TCR y chains are ' The nomenclature used for human Vy and Jy gene segments is that of Strauss et al . (66). The relationship between this scheme and that of Lefianc et al . (12, 67) is described in Ref. 63 . The nomenclature for human VS gene segments is that of Hata et al. (8) and Takihara et al . (50), and for human DS and JS gene segments is that of Loh et al. (47) . encoded by the Cy2 genesegment . The explanation for the presence of relatively discrete populations of TCR-y/b lymphocytes is unclear.
revious studies of clonal and polyclonal human TCR-y/b lymphocytes derived from peripheral blood have revealed the presence of two major subpopulations based upon variable (V) and constant (C) gene segment usage (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . The majority of peripheral blood TCR yb lymphocytes bear receptors using both V62 and Vy2 (Vy9 in the nomenclature of Lefranc et al. [12] ).' The TCR y and b chains of these receptors are disulfide-linked, indicating that the TCR y chains are encoded by Cy l rather than Cy2 (13, 14) . A smaller population of peripheral blood TCR-y/S lymphocytes bear receptors using V61. The majority of these lymphocytes use members of the V.y1 gene family, rather than VY2, and the TCR y and b chains of these receptors are frequently non-disulfide linked, indicating that the TCR y chains are ' The nomenclature used for human Vy and Jy gene segments is that of Strauss et al . (66) . The relationship between this scheme and that of Lefianc et al . (12, 67) is described in Ref. 63 . The nomenclature for human VS gene segments is that of Hata et al. (8) and Takihara et al . (50) , and for human DS and JS gene segments is that of Loh et al. (47) .
encoded by the Cy2 genesegment . The explanation for the presence of relatively discrete populations of TCR-y/b lymphocytes is unclear.
Analysis of the ontogeny of murine TCR-y/b lymphocytes indicates that rearrangements at the TCR-y and -b loci occur in an orderly fashion (15) (16) (17) (18) (19) . The first detectable wave of rearrangements in early fetal thymocytes involves the V.y32 and Vat gene segments. A distinct population of late fetal thymocytes displays rearrangements of the Vy4 and V61 gene segments. These early rearrangements are also characterized by lowjunctional diversity, since there is minimal incorporation of template independent N region nucleotides, and only the 3' D6 segment (D62) is used. Murine dendritic epidermal y/b cells apparently originate from the early V .,3-V61 population of fetal thymocytes, and mucosal intraepithelial lymphocytes apparently originate from the subsequent Vy4V61 population (20) (21) (22) . Adult thymocytes display rearrangements involving distinct Vy and Va gene segments, and display extensive junctional diversity (23, 24) .
Based upon indirect evidence it has previously been suggested that rearrangements within the human TCRy locus may be ordered (25) . It was proposed that the initial rearrangements at this locus join the downstream Vy gene segments (i .e ., Vy2, Vy3, Vy4) to the upstream Jy gene segments (i .e., those associated with Cyl: Jy1.1, Jy l.2, Jy l.3), whereas subsequent rearrangements join the upstream Vy gene segments (i .e ., members of the Vyl family) to the downstream Jy gene segments (i.e., those associated with Cy2: Jy2.1, Jy2.3). To date, this has not been confirmed by the direct analysis of gene rearrangements in early human fetal thymocytes. Further, no information is available concerning the sequence of rearrangements at the human TCR-6 locus.
In this manuscript we have analyzed TCR-y and TCR6 gene rearrangement and expression in clonal and polyclonal early fetal and postnatal human TCRy/b thymocytes . We show directly that early TCR-y rearrangements join downstream V segments to upstream J segments, that these rearrangements occur coordinately with an early wave of Va2 rearrangements at the TCR6 locus, and that these early TCRy and -6 gene rearrangements display limitedjunctional diversity.
Since our analysis showed the TCRs expressed by early fetal TCRy/b thymocytes to be distinct from those of postnatal TCRy/b thymocytes, we asked whether these cell populations represent functionally distinct subsets as well . We found that fetal TCR-y/b thymocyte clones were able to secrete significant levels o£ I1r4 and ID5, whereas postnatal clones did not secrete these cytokines. Both sets of clones produce high levels of granulocyte/macrophage CSF (GM-CSF) 3 and IFN-y.
Materials and Methods
Establishment of TCR-y/6 Thymocyte Clones. Postnatal thymuses were obtained from children undergoing corrective heart surgery and were kindly provided by Dr. D. Regal, Centra de Transfusion Sanguine, Lyon, France . Fetal thymic material was obtained from J. L. Touraine, Hopital Eduard Herriot, Lyon, France . Thymocyte suspensions were prepared by gently teasing thymus tissue into a single cell suspension . An entire lobule was used to ensure that both cortical and medullary cells were represented . The fetal thymocyte samples and the samples from child thymus OM were cultured in a mixture of 20 U/ml 11,2 and 100 U/ml 11,4 for 10 d. This procedure increased the number of TCRy/6 cells from <1% to 10% (OM), 5% (Solo), 6% (BB), and 7% (CC) . The cells were then stained with antiTCR-S1, which recognizes an epitope on the TCR 6 chain, and were washed and incubated with goat anti-mouse-labeled human red blood cells. The TCRy/6* cells were enriched as described previously (26) . TCRy/6 cells of individual FH (4 mo old) were isolated from a fresh thymocyte sample using acombination of magnetic bead and FRCS sorting as follows: thymocytes were incubated with anti-CD4 (RIVE; kindly provided by Dr. Kreeftenberg, RIV, Bilthoven, Netherlands) and anti-CD8 (WT82 ; a kind gift from Dr. W Tax, University of Nijmegen, 'Abbreviation used in this paper: GM-CSF, granulocyte/macrophage CSF. Netherlands) mAbs for 30 min at 4°C, and were washed and then incubated with biotinylated goat anti-mouse antibody (Tago, Inc., Burlingame, CA) for 30 min. After washing, the cells were incubated for 5 min with FITC-labeled avidin (Becton Dickinson & Co., Mountain View, CA), and subsequently with biotinylated magnetic beads. CD4* CD8* cells were then removed on a MACS (27) . The remaining FITC-labeled cells were then removed by sorting on a FACStar plus (Becton Dickinson) . 50% of the depleted cell population stained with PE-labeled anti-CD3 (PELen 4, Becton Dickinson) and <0 .5% of the cells were CD4* CD8* as indicated by reanalysis of the sorted cells. The CD4-CD8-FH cells and the TCRy/6 enriched cultures of Solo, BB, CC, and OM were cloned by limiting dilution at 0.3 cell per well in a 96-well plate (Linbro, Flow Laboratories, McLean, VA) in the presence of a feeder cell mixture consisting of 5 x 101/ml irradiated (4,000 rad) PBL, 5 x 10`/ml irradiated (5,000 rad) cells of the EBVtransformed B cell line JY, and 0.1 Ag/ml purified PHA (Wellcome Diagnostics, Dartford, England) . Yssel's medium (28) was used for all cell cultures . The clones were expanded by weekly stimulations with the feeder cell mixture. 3 d after each stimulation, the cultures were split and 20 U/ml rIlr2 was added. The feeder cells deteriorated between day 2 and 4 and at day 5 or 6 no feeder cells were visible or detectable with mAbs specific for B cells, monocytes, or TCR-a/o (data not shown) . For molecular analysis of V, and Va usage, bulk cultures of the enriched BB and CC cells were maintained by weekly stimulations with feeder cells and PHA.
Monoclonal Antibodies and Immunofluorescence The antiTCR y/6 mAb TCR-61 (29) was a kind gift of Dr. M. Brenner (Dana Farber Cancer Institute, Boston, MA); 6TCS1(30) was purchased from T Cell Sciences Inc. (Boston, MA); and the mAbs BB3 (31) and TiyA (32) andwere gifts from Drs. L. Moretta (Genova, Italy) and T Hercend (Institute Gustave Roussy, Paris, France), respectively. Characterization of the TCRy/6 T cell clones was carried out as described previously (28) . Two hundred thousand cells were incubated with mAb for 30 min at 4°C, washed, and then incubated with FITC labelled goat anti-mouse F(ab)2 fragments (Tago Inc., Burlingame, CA) for 30 min at 4°C. Cells were washed and analyzed on a FACScan.
DNA Fragments and Oligonucleotides. The 5'Da probe is a 1.3-kb ECORI-Bam HI fragment mapping 5' of Dal that was isolated from the genomic clone BSK61(a gift of S. Ang, Harvard Medical School, Cambridge, MA). All other DNA probes have been described previously (8, (33) (34) (35) . Oligonucleotides used for the PCR were : Vat, 5'GGGGTCGACAAGTTGGTGGTCATATTA; Vat, TGGGGTCGA000TCAGGPGCTCCATGAA; Va3, 5'000GTC-GACACTGTATATTCAAATC; V«17 (=Va5), 5'000GTCGACT ATACTAACAGCATGTT; Vyl, 5'TACATCCACTGGTACCTAC-ACCAGGA; V,2, 5'GGGGTCGACCTGGTGAAGTCATACAGT Jal, 5'GGGGAATTCCACAGTCACA000GTTC; Ja3, 5'000-GAATTCCACGAAGAGTTTGATGCC ; J,1.1, 5'000GGATCC-AGTTACTATGAGCTTAGTCC; J,1.3, 5'G000GATCCTGTG-ACAACAAGTGTTGT.
Preparation and Blot Hybridization of Genomic DNA and RNA. Genomic DNA and RNA were prepared by established procedures (36, 37) . Gel electrophoresis, blotting, hybridization with 11 Plabeled probes, and washing were as described previously (8) .
Polymerase Chain Reaction. Genomic DNA (0 .514g) was heated to 94°C for 7 min and was amplified under mineral oil for 35 cycles in a 25 Pl reaction containing 0.2 mM each deoxyribonucleotide triphosphate, 50 mM KC1, 1.25 mM MgCl2, 0.01% gelatin, 100 mM Tris-HCI (pH 8.3), 1 U Taq polymerase, and 20 pmol each oligonucleotide (38) . Each cycle consisted of a 0.8 min denatura-tion step at 94°C, a 1.0-min annealing step at 51°C, and a 2.0-min. extension step at 72°C. The extension step following the last cycle was for 9.9 min . One-fifth of each reaction was analyzed by agarose gel electrophoresis. The remainder was extracted with chloroform, phenol/chloroform (1:1), and chloroform, and was ethanol precipitated. Pelleted DNA was resuspended, digested using appropriate restriction enzymes, and purified through low gelling temperature agarose. Fragments were then cloned into appropriately digested vectors prepared from Bluescript KS+ (Stratagene, LaJolla, CA), and plasmid minipreps were prepared . When DNA from a polyclonal cell source was amplified, secondary transformants and minipreps were prepared in order to obtain pure clones. Nucleotide sequences were determined on both strands by the dideoxy chain termination method using double-stranded templates (39) and modified T7 polymerase (40) (Sequenase; U.S. Biomedical Corp., Cleveland, OH) .
Stimulation of T Cell Clones and Assays for Cytokine Production.
Cells were stimulated on day 7 after the last stimulation with feeder cells, and were collected, spun, and then washed two times with medium. The cells were stimulated at a concentration of 106 cells/ml per well of a 24-well plate (Linbro) . 24 h later the supernatant was removed, spun at 250 g, frozen, and kept at -20°C until testing . IL4 (41), IL-5 (42), IFN-y (43), and GM-CSF (42) were determined by ELISA as described . 11,2 levels were determined using the IL2-dependent cell line CTLL2 as described (44) .
Results
Analysis ofCell Surface Expression of TCR-y/d on Thymocyte Clones. Thymocytes of three different fetal samples were obtained: Solo (8.5 wk of gestational age), BB (12 wk), and CC (15 wk) . Postnatal thymus samples were obtained from two children: OM (6 mo old) and FH (4 mo old). The procedures to obtain the Solo, BB, CC, and OM clones were similar. Thymoctes were cultured in IL-2 and 11,4 for 10 d, and the (5, 6, 10, 47) . In contrast to these results with postnatal thymorytes, all of the Solo, BB, and CC fetal thymus clones reacted with the BB3 mAb, and none reacted with &CS1( Table 1) . Most of these were also TiyA+, indicating coexpression of Va2 and Vy2, although two of the three Solo clones (Solo 6 and 15) were TiyA-. In addition, at early stages in the expansion of the polyclonal BB and CC cultures a small fraction of the cells were BB3+ and TiyA-(data not shown), although all of the clones obtained were BB3+ TiyA+ . These data suggest that Va2 is the predominant Va gene segment used in early fetal thymorytes, and that although V72 is also used with high frequency, Vs2 usage is not strictly linked to Vy2 usage within this cell population, despite coordinate usage in peripheral blood (4, (8) (9) (10) . TCR-y and -6 Rearrangements in Postnatal Thymocytes. To extend the above findings, we first analyzed the TCRy and TCR-6 gene rearrangements and transcripts in the OM postnatal thymocyte clones. By hybridization with a Jyl.3/2 .3 probe in KpnI and EcoRI digests of genomic DNA, and with Vy2 and Vy3 probes in KpnI digests, we identified two rearrangements in each T cell clone. Some rearrangements were further characterized by sequence analysis of PCR products amplified from genomic DNA using V andJ specific oligonucleotide primers. We found the array of rearranged V,. gene segments to be heterogeneous, including multiple members of the Vy1 family, as well as Vy2 and Vy3 (Table  2 ). Based on these results and on surface staining with the TiyA mAb (Table 1) , OM35 carries an in-frame Vy2 rearrangement, and OM54 and OM64 carry in-frame Vyl.4 and Vyl.8 rearrangements, respectively. OM47 displays predominantly Vyl transcripts, and therefore is likely to carry an in-frame Vyl.3 rearrangement. Despite the observed heterogeneity in the rearranged V gene segments, it is striking that seven of the eight rearrangements in these cells involve Jy segments upstream of Cy2, namely, Jy2.1 and Jy2.3 .
Assignment of the TCR-S gene rearrangements in these cells was accomplished by hybridization of Jal, Ja3, Vat, Vat, 5'Da, and Vg17 probes to Xbal digests of genomic DNA. The V.,17 probe was included because this V segment has been previously mapped to the genomic region between the Val and Va2 gene segments (35 
Nucleotide sequence analysis of TCR-S gene rearrangements in postnatal thymocyte clones. (A) functional sequences were determined from PCR products amplified using appropriate pairs of primers . D elements were assigned with the requirement for a minimum of three contiguous matches to the germline sequence . P nucleotides were assigned according to reference 19. Deduced amino acid sequences are in the single letter code ; a shift to lowercase letters indicates a shift to an inappropriate reading frame. (B) The nucleotide sequence of the amplified portion of the OM47 V segment is compared with the analogous portions of three previously reported V sequences : L17 Vim, (48) , V65 (50) , and V .17.1 (49) . The V OM47 sequence was confirmed using multiple DNA templates . Differences between this sequence and the published sequences are noted.
ysis of VDJ junctional regions amplified by PCR, one of the two Vs1 rearrangements in OM35, as well as the V63 and Va1 rearrangements in OM54 and OM64, respectively, are in-frame (Fig. 1 A) . Analysis of both Northern and Southern blots using the V,,17 probe revealed the rearrangement of V.17 or a highly homologous V segment to Jai in OM47. The nucleotide sequence ofthe VDJjunction of this rearrangement following PCR amplification (Fig. 1 A) demonstrated it to be in-frame . The sequence of a portion of the rearranged V segment is 851 Krangel et al .
compared with three other closely related sequences in Fig.  1 B. The VOM47 sequence differs from the previously described L17 V« (48) cDNA sequence by a single nucleotide, and from the previously described Vg17.1 (49) sequence by six nucleotides. Furthermore, a recently identified Va segment denoted Vas (50) also differs from the VOM47 sequence by a single nucleotide, and is identical to L17 V,,,.
Since an L17 V« probe detected only a single hybridizing sequence on Southern blots (data not shown), the different sequences must represent polymorphic variants of the same V gene segment . Thus, this V segment, which maps to the proximal portion of the human TCRa/S locus, can rearrange to both Da and J,,, segments, and thereby serves as both a Va and a V,,, . The analysis of a truncated cDNA clone representing the 3 .9-kb Jal rearrangement in OM54 revealed an out-of-frame rearrangement involving a previously undescribed V segment that maps between V~17 (=VaS) and Va2 (data not shown) . The 3.2-kb J6 1 rearrangement in OM64 was not characterized .
TCR--y and -S Gene Rearrangements in Early Fetal Thymocytes . We next analyzed the TCR--y and -S gene rearrangements in the 8.5-wk fetal thymus clones Solo 6, 15, and 19, and found them to be strikingly different from those observed in the postnatal thymocyte clones ( Table 2 ). Southern blots revealed the rearrangement of both Vy2 and Vyl gene segments. Notably, all five TCR--y rearrangements were found to involve the Jyl, rather than the Jy2 cluster, whereas one chromosome was in the germline configuration . To identify the rearranged Vy1 gene segments, each VJ rearrangement was amplified by PCR using an oligonucleotide that anneals to all Vyl sequences as a 5' primer, and aJy1.1 oligonucleotide as a 3' primer. Nucleotide sequence analysis indicated the rearrangement of V.y1.8 in every instance and showed that Solo 6 and Solo 15 each carry a single in-frame Vy 1.8 rearrangement (Fig. 2) . Similar PCR analysis revealed the Vy2 rearrangement in Solo 19 to be in-frame, and that in Solo 6 to be out-of-frame (Fig. 2) , in accordance with staining results (Table 1) .
Together with the staining analysis of the Solo, BB, and CC clonal and polyclonal lines (Table 1) , the above results indicate that whereas Vy2 rearrangements are common in early fetal thymocytes, Vyl rearrangements occur as well. Further, these results suggested that the rearrangement of V.y1 gene segments in early fetal thymocytes might not be random . To specifically address this issue, we analyzed DNA prepared from polyclonal BB and CC cultures by PCR using V .,1 and JyM primers. Six of six clones sequenced that were obtained following amplification of BB DNA used V.Y1.8 (Fig. 3) . Two of four clones obtained following amplification of CC DNA used V.J.8, whereas one clone each used Vy1.3 and VJ.4. All clones were independent based upon their VJ junction nucleotide sequences. Further, 8 of 10 were out-offrame, in accordance with staining data indicating the BB and CC cultures to be composed primarily of TiyA+ TCR y/S lymphocytes and TCR-oi/a lymphocytes. These results provide strong evidence that Vyl rearrangements in early fetal thymocytes involve Vyl.8 almost exclusively, at least Figure 2 . Nucleotide sequence analysis of TCR-6 TCR-y gene rearrangements in fetal thymocyte clones. functional sequences were determined from PCR products . amplified using appropriate pairs of primers . They are compared with the relevant germline gene segment sequences (underlined) . All sequences were confirmed using multiple DNA templates. The Vy segments involved in all three rearrangements amplified using Vy l and Jyl .l primers could be assigned as Vy 1 .8 based on a comparison of the sequences determined 5' of the junctional region with those reported in reference 12 (see for example 
Analysis of TCR-6 rearrangements in the Solo clones revealed the Vat gene segment to be the only V6 segment rearranged in these cells (Table 2) . Solo 15 displays two V62 rearrangements and Solo 19 displays a V62 rearrangement on one chromosome and retains the germline configuration on the other chromosome. Solo 6 displays one V62 rearrangement and on the other chromosome displays a previously uncharacterized 4.4-kb rearrangement detected by the J63 probe in an XbaI digest. We conclude that this represents a partial rearrangement (D-J or D-DJ) involving J62 for the following reasons: First, the genomic region hybridizing with the 5'D6 probe has been retained on one chromosome, arguing that on this chromosome rearrangement has not proceeded 5' of D61. Second, the intensity of hybridization ofthe rearranged fragment is equivalent to germline as assessed with a J63 probe; since the probe straddles J63, hybridization is significantly diminished upon rearrangement of Jai, but not J62. Finally, although the V63 gene segment maps 3' of C6 and would not delete the region hybridizing to the 5'Da probe upon rearrangement, the predicted size of a V63 J62 rearranged fragment is only 3.3 kb.
The VDJ junctional regions of the V32 rearrangements in these cell lines were amplified by PCR and their nucleotide sequences were determined (Fig. 2) . Notably, all four rearrangements were found to be functional. Solo 15 therefore displays two in-frame rearrangements, and possibly two y/6 TCRs on its cell surface . This apparent violation of allelic exclusion could have arisen if the two rearrangements occurred nearly simultaneously. However, it is intriguing that other reports have suggested that allelic exclusion at the TCR a .locus may not be complete (51) (52) (53) . Nevertheless, these data, along with the results of surface staining ( Table 1 ), argue that V62 rearrangements predominate in early fetal thymocytes, even though, as demonstrated in this and in other studies, they are rare in postnatal thymocytes (5, 6, 10, 47) .
Minimal Diversity ofEarly Fetal Thymo to TCR-y and -a V-(D}J functions. A striking feature of the TCR-y and -8 junctional sequences presented in Fig. 2 is the limited diversity they display relative to the junctions of rearrangements in postnatal thymocytes (Fig. 1 A) (47) and peripheral blood lymphocytes (7, 8, 34, 47) . Two of the five TCR y VJjunctions analyzed display no incorporation oftemplate independent N-region nucleotides, and a total of only six N-region nucleotides are seen in the fivejunctions analyzed. The TCR6 VDJ junctions are even more striking. They reveal only two N-region nucleotides among the four sequences, with three of the junctions displaying no N-nucleotide incorporation . Further, the only Da segment used is D63 . Hence, these VD-Jjunctional sequences bear marked similarities to those described for TCR-S gene rearrangements in very early murine fetal thymocytes : the use of a single V gene segment, the use ofonly the 3' D gene segment, and minimal N nucleotide incorporatipn (16-19) .
To confirm and extend these findings, we analyzed thejunctions o£;Va2 rearrangements in the polyclonal BB and CC fetal thymocyte cultures. Southern blot analysis of Xbal 85 2 Human T Cell Receptor .y/6 Lymphocytes in the Farly Fetal Thymus 
digested BB and CC genomic DNA using a radiolabeled Vat probe revealed that in both populations Vat rearrangements to Ja3 predominated over those to Jal (data not shown) . We then used PCR to amplify both types ofjunctions in each sample . The analysis of 13 junctions of 12-wk fetal thymocytes and 17 junctions of 15-wk fetal thymocytes is presented in Fig. 4 . All 30 junctions display portions of the Da3 gene segment . By contrast, only three display possible contributions from Dal, and two from Dal . However, since in these instances the maximal contribution is only three nucleotides, apparent Dal and Da2 contributions could have arisen by chance. We conclude that Dal and Da2 rearrangements are rare events in early fetal thymocytes. These junctions also display minimal incorporation of N-region nucleotides. Roughly one-third of the 12-wkjunctions, and one-half of the 15-wk junctions, display no N nucleotides. The average number of N-nucleotides per junction increases from 0.5 at 9 wk to 2.4 at 12 wk and 2.7 at 15 wk. When only N-nucleotide positive junctions are considered, these numbers increase to 2.0 at 9 wk, 3.7 at 12 wk, and 5.4 at 15 wk. By contrast, the sequences offive different Figure 4 . Nucleotide sequence analysis of TCR-S rearrangements in polyclonal 12-and 15-wk fetal thymocytes. functional sequences were determined from PCR products amplified from BB and CC DNA using appropriate pairs of primers. They are compared with germline sequences (top), fetal thymocyte clone sequences (Solo, Fig . 2) , and postnatal thymocyte clone sequences (OM, Fig. 1 A) . Numbers along the left border denote the Va segment used (Va1,2,3,5) and those near the right border denote the Ja segment used (1x1,3) . Sequences are classified as either in-frame (+) or out-of-frame (-) along the right border.
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junctions from the OM postnatal thymocyte y/S T cell clones (using Vat, Va3, and Va5) reveal in most instances the usage of both Da3 and Dal, and display much more extensive N-nucleotide incorporation (15 .8 per VD-DJjunction) (Figs. 1 and 4). To determine whether the differences noted between early fetal and postnatal thymocyte TCR-S junctions are related to the age of the sample rather than the particular V gene segment rearranged, we amplified by PCR a single rare example of Val to Ja3 rearrangement in each of the polyclonal fetal thymus samples (Fig. 4) . Bothjunctions display the use of only the DO gene segment, and display no N-nucleotide incorporation . These data therefore argue that TCR-S junctional diversity increases in an age-related fashion throughout early thymic development, and is only indirectly associated with V segment usage.
Cytokine Production by Fetal and Postnatal TCR-ylb Thymocyte Clones. In order to reveal possible functional differences between the Va2+ fetal and Vat -postnatal thymocyte clones, we analyzed the capacity of the clones to produce cytokines upon stimulation. Therefore the clones were stimulated with 30 14g/ml ConA, a powerful polyclonal stimulant for human T cell clones (54) , and the supernatants were assayed for 11,2, ID4, IM, IFN-y, and GM-CSF. Table 3 shows the cytokine production profiles of seven fetal TCRy/S clones from samples Solo, BB and CC, and seven postnatal TCR-,y/S clones from donors OM and FH. All fetal clones produced significant levels of ID4 after activation with ConA. The fetal clones also produced 11,5 and high levels of GM-CST and IFN-y . Three additional fetal clones also produced I1r4 and M after activation, but one (CC40) consistently failed to produce 11,4 or IM, and secreted low levels ofGM-CSF but significant amounts of IFN-y (data not shown) . In contrast to the fetal clones, the clones derived from postnatal thymic material did not produce IIr4 or 11,5 above background (Table 3 ). In general, the clones produced less GM-CSF than the fetal clones, although the levels of lL2 and IFN-y were comparable ( Table 3 ). The same pattern of cytokine production was observed with five other postnatal TCRy/S thymocyte clones (data not shown) .
To determine the capacity of these clones to produce cytokines after activation via the TCR/CD3 complex or CD2, they were stimulated with a CD3 mAb in the presence or absence of the phorbol ester PMA or by a mitogenic combination ofanti-CD2 mAbs. As a control, the clones were stimulated with PMA alone, a treatment that normally cannot activate mature T cells on its own (54) . The cytokine production pattern of three representative fetal and three postnatal TCRy/S clones is presented in Table 4 . The combination of anti-CD2 mAbs was able to induce cytokine production in all clones. As expected, the anti-CD3 mAb SPVT3b only induced cytokine production in combination with PMA . Interestingly, PMA alone activated the cells to produce cytokines. Whereas 1 ng/ml PMA was sufficient to trigger secretion of significant levels of cytokines (data not shown), 10 ng/ml was found to be optimal . The patterns of cytokine production after activation via CD2 or TCR/CD3 were the same as after activation via ConA, inasmuch as the fetal thymo- T ACTGGGGGATACG  ACT  TGGGAC 3 +  GGGATACG  TA  CTGGGAC 3 +   T ACTGGGGGATACG  G  CTGGGAC 3 +  GGGGGATA  CTCCTGGGAC 3 +   T ACTGGGGGAT  ACACCGATAA I +  2 GAC  TGGGGGAT  ATM 1 -2 GACAC  TGGGGGAT  ACACCGATM 1 +   2 GACAC  GGC  GGGATA  CGATAA 1 +  2 GAC  GCGCC  T ACTGGGGGATACG CG  AAAGGGG  G CTCCTGGGAC 3 +  2 GACACC  GGGG  TC  AS CTOCTGGGAC 3 +  2 GACACC G  CA  GGGGG  CTCCTGGGAC 3 +   2 GACACC  ACTGGGGGATA  CTCCTGGGAC 3 +  2 GACACC  TGGGGG  TC  CTCCTGGGAC 3 +  2 GALA  AAA  T ACTGGGGGATAC  CTGGGAC 3 +  2 GACAC  TGGGGGATA  CTGGGAC 3 +  2 GACACC G  TAAG  TGGGGGATACG C  TC  CCTGGGAC 3 +  2 GACACC  GA  GGGG  TCACGGTC  CCTGGGAC 3 -2 CAC  CGG  GT ACTGGGGGAT  CGG  AG CTCCTGGGAC 3 +  2 GACACC  GGGGGATA  CTCCTGGGAC 3 +  2 GACA  GA  GT ACT000  ACAA  AG CTCCTGGGAC cytes produced 11,4 and Ilr5, whereas the postnatal thymocytes secreted at most only very low levels of these cytokines (Table 4) .
Discussion
By analyzing the rearrangement and expression of the TCR y and -6 genes in early human fetal thymocytes we have obtained strong evidence that rearrangement at these loci occurs in an orderly and coordinated fashion, summarized schematically in Figure 5 . Our data indicate that the initial rearrangement events at the TCR-6 locus involve the joining of the Vs2 gene segment to the DO gene segment . The initial rearrangement events at the TCR-y locus involve the joining of downstream Vy gene segments, primarily Vy1. and Vy2, to Jy gene segments of the Jyl cluster. At later times there is a switch in the rearrangement pattern at the TCR-6 locus such that the Vs1 gene segment (as well as some other Vs gene segments), is joined primarily to the upstream Ds gene segments, Ds1 and Ds2 . Similarly, there is a switch in the rearrangement pattern at the TCR y locus such that upstream Vy gene segments in the Vyl family are joined to downstream Jy gene segments of the Jy2 cluster. Superimposed on this highly ordered rearrangement pattern is a gradual increase in diversification at the junctions of the rearranged gene segments through the incorporation of template-independent N region nucleotides. Our results are almost certainly due to control at the level of gene rearrangement rather than to selection based upon surface TCR expression, since the out-of-frame rearrangements that were anaLymphocytes in the Early Fetal Thymus 7 d after the previous stimulation, cells were washed twice and stimulated at a concentration of 10 6 cells/ml with a combination of 1 tzg/ml purified SPV-T3b (70) and 1 ng/ml PMA, 10 ng/ml PMA, or a 1:2,500 dilution of ascites of the anti-CD2 mAbs X.11-1 and D66 (71) . Each value is the mean ± SD of duplicate determinations. One of three representative experiments is shown.
lyzed displayed properties that were highly similar to the in-frame rearrangements . Previous studies have shown that the predominant population of TCRy/S lymphocytes in human peripheral blood displays cell surface TCRs that pair TCR 6 chains using Vs2 with TCR y chains using Vy 2-Cy l (4, (8) (9) (10) . We have previously demonstrated in transfection experiments that there is no physical barrier that prevents Vs2+ TCR 6 chains from pairing with Vy l-Cy2 TCR y chains (46) . Consistent with 85 5 Krangel et al .
this result, and the recent analysis of a large panel of postnatal thymocyte clones (10), we find that two of three early thymocyte clones display cell surface TCRs composed of Vs2+ TCR 6 chains paired with Vyl.8-Cyl TCR y chains. We therefore suggest that the predominant Vs2/Vy2-C yl peripheral blood population arises as the result of two distinct processes . Coordination between rearrangement events at the TCR-y and -6 loci as described here dictates that TCR y1b lymphocytes that use Vs2 will also express TCR y 1, 8, 10 ) . These observations argue that selection must also play an important role in generating this specific cell population . In this regard, it is important to note that Parker et al. (55) have recently provided evidence for postnatal, extrathymic expansion of the V62/Vy2-C7 1 subset. Although we do not have formal evidence that the early fetal thymocytes analyzed in this study include the precursors of the predominant V62/Vy2-Cyl population in adult peripheral blood, a number of observations argue that this is probably the case. A comparison ofour data on fetal and postnatal thymocyte TCR S VDJ junctions to similar data accumulated from peripheral blood TCR-,y/S lymphocytes argues that the V61+ and V62+ subsets arise via rearrangements occurring at distinct phases of thymic ontogeny. Peripheral blood and postnatal thymocyte V61 junctions typically display contributions from multiple D6 segments, rather than solely from D63, and display extensive N-nucleotide incorporation (this study; 34, 47, 50) . By contrast, the peripheral blood V62 junctions are generally less complex, often displaying a contribution from only D63, and less extensive N-nucleotide incorporation (7, 8, 50) . Further, J63 usage, which apparently predominates in early fetal thymocytes, is much higher in the peripheral blood V62+ subset than in the peripheral blood V61 + subset (8, 10, 34) . Taken together, these observations suggest that a significant fraction of the V62/Vy2-C yl lymphocytes in peripheral blood are generated relatively early during thymic ontogeny. Whether a subset of the early fetal thymocytes also serves as the precursor of a population of human TCR-y/b lymphocytes with a distinct anatomical localization cannot be eliminated, however.
Our data demonstrate remarkable similarities between the earliest rearrangement events at the human and murine TCRy and -b loci. In both systems the repertoire of rearrangeable V gene segments is initially highly restricted, and the usage of homologous D6 gene segments (D63 in the human, D62 in the mouse) and J6 gene segments U63 in the human, J62 in the mouse) predominates (16, 18, 19) . Further, junctional diversification by the incorporation of N-region nucleotides is minimal or absent in both systems at early times, presumably as the result oflow levels ofterminal transferase activity (56) . However, the analysis of the V(D) J junctions of early murine fetal thymocytes that use specific pairs of V7 and V6 gene segments has also shown them to be highly homogeneous, and to encode the TCRs expressed on adult lymphocytes in certain epithelial locations (19) (20) (21) (22) . In marked contrast, the V62-D63-J63 junctions analyzed here are quite heterogeneous. The junctions of the Solo clones were all distinct, and did not match any of thejunctions obtained from the polyclonal BB and CC cultures . None of the CC junctions occurred more than twice among the sequences examined, and although one BB junction was detected at high frequency, it seems most plausible to attribute this result to oligoclonality as the result of expansion of the BB culture in vitro. These results would argue that early human TCR-,y/b lymphocytes might not be subjected to the same types of intrathymic selection that limit the repertoire of certain intraepithelial lymphocytes in the mouse (19) (20) (21) (22) .
Striking differences were found in the capacities of fetal and postnatal TCRy/b thymocytes to produce cytokines upon activation, suggesting that these two sets ofTCR-y/b thymocyte clones represent functionally distinct subpopulations. In contrast to postnatal TCR-7/6 thymocyte clones, the fetal clones produced significant levels of IL4 and IL-5 after activation with either the lectin ConA, anti-CD3 mAb plus PMA, or a mitogenic pair of anti-CD2 mAbs. Both sets of clones were able to secrete GM-CSF and IFN-.
y . The failure ofpostnatal TCR--y/S thymocyte clones to produce 11,4 is probably due to a lack of11,4 gene transcription, because with a highly sensitive PCR technique no IL4 mRNA could be detected after activation ofthe clones with ConA (De Waal Malefyt, R., and H. Spits, unpublished data). Since the postnatal and fetal clones were cultured under identical conditions, the inability of the postnatal clones to produce 11,4 and IL5 is not acquired in vitro. Moreover, freshly isolated day 13-15 murine CD3+ fetal thymocytes that contain only TCR-y/b cells produce 114 upon stimulation with anti-CD3 mAb (57) . We believe, therefore, that the fetal TCR-y/b cells have the ability to produce 114 and 1175 in vivo. The cloned TCRy/b lines produced cytokines upon activation via the CD3/TCR-y/b complex or via CD2, but whether or not TCR-y/b cells are actually stimulated in vivo to produce IL4 and 11,5 is unknown . In situ hybridization should be carried out to investigate this point .
TCR-y/b thymocytes might play a role in early TCR-ct/(3 T cell development, and if so, cytokines are presumably involved . Our data could therefore be an indication that IL4, IL-5, or both, are important regulators of early thymic development. In man, the main target cell of 11,5 is the eosino-phil (58) . In addition, some effects of IIr5 on human B cells have been documented (58, 59) , but so far no effects of IIr5 on human T cells have been reported . It is therefore unclear what the biological significance is of IM for thymic development . On the other hand, T cells can respond to 11,4. While activated mature human T cells proliferate in response to IIr4 (60) , this factor can inhibit activation of resting human T cells under certain conditions (61) . In the mouse, CD4 -CD8 -day 15 fetal thymocytes respond to 114 in the presence of PMA, although they do not acquire CD4 or CD8 under these conditions (62) . In addition, mature CD4+ CD8 -and CD4 -CD8+ thymocytes proliferate in response to IIA both in mouse and in man (60, 63) . Fetal human thymocytes cultured for 14 d in IIr4 contain an elevated percentage
